Related Experiment Video
Updated: May 5, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
Granulomatous scleromyxedema: case report and literature review
Julia Shlyankevich1, Galina Y Stetsenko, Evan George
1*School of Medicine, University of Washington, Seattle, WA; †Department of Medicine, Division of Dermatology, University of Washington, Seattle, WA; ‡Department of Pathology, University of Washington, Seattle, WA; and §Department of Medicine, University of Washington Medical Center, Seattle, WA; and Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA.
Abstract:
Scleromyxedema is a rare and frequently disabling disease characterized by generalized waxy papules, skin induration, and cardinal histological features of dermal fibroblastic proliferation, thickened collagen, and mucin deposition. A monoclonal gammopathy is almost always present with rare progression to multiple myeloma. We describe the case of a 54-year-old man who presented with a rash in the setting of a new medication and histological features suggesting a granulomatous drug reaction. Despite discontinuation of the medication, the rash persisted and a second biopsy confirmed an interstitial granulomatous pattern. Serum protein electrophoresis identified the presence of a biclonal gammopathy leading to a diagnosis of granulomatous scleromyxedema. Review of the medical literature reveals only a handful of well-documented similar cases of this rare variant. It is important for pathologists and clinicians to be familiar with this condition to facilitate timely diagnosis and optimal clinical management of these patients.
Related Concept Videos
Cirrhosis I: Introduction
Nephrotic Syndrome I : Introduction
